Bank of America’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-6,386
| Closed | -$155K | – | 7554 |
|
|
2017
Q4 | $155K | Buy |
6,386
+2,547
| +66% | +$49K | ﹤0.01% | 5525 |
|
|
2017
Q3 | $70K | Sell |
3,839
-150
| -4% | -$2.6K | ﹤0.01% | 5815 |
|
|
2017
Q2 | $66K | Sell |
3,989
-3,429
| -46% | -$47.7K | ﹤0.01% | 5776 |
|
|
2017
Q1 | $102K | Buy |
7,418
+2,594
| +54% | +$41.6K | ﹤0.01% | 5622 |
|
|
2016
Q4 | $92K | Sell |
4,824
-32,756
| -87% | -$628K | ﹤0.01% | 5669 |
|
|
2016
Q3 | $834K | Buy |
37,580
+36,514
| +3,425% | +$686K | ﹤0.01% | 4285 |
|
|
2016
Q2 | $19K | Sell |
1,066
-56
| -5% | -$964 | ﹤0.01% | 6279 |
|
|
2016
Q1 | $20K | Sell |
1,122
-1,881
| -63% | -$30.4K | ﹤0.01% | 6145 |
|
|
2015
Q4 | $51K | Sell |
3,003
-23,501
| -89% | -$399K | ﹤0.01% | 6036 |
|
|
2015
Q3 | $478K | Buy |
26,504
+23,558
| +800% | +$525K | ﹤0.01% | 4836 |
|
|
2015
Q2 | $76K | Buy |
2,946
+2,866
| +3,583% | +$72.4K | ﹤0.01% | 5749 |
|
|
2015
Q1 | $2K | Buy |
+80
| New | +$1.73K | ﹤0.01% | 6730 |
|
Bank of America's ENTL Position: Q1 2018 in Review
Bank of America sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 6,386 shares — an estimated $155K sold.
Bank of America first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $834K in Q3 2016. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.
- Bank of America reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
- Bank of America sold 6,386 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $155K.
- Bank of America first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
- Bank of America's Entellus Medical, Inc. Common Stock position peaked at $834K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.
Based on Bank of America's 13F filing for Q1 2018, filed 15 May 2018.